I'm A Patient
I'm A Provider
Direct Answer
Vancouver has a well-developed eye care community with ophthalmologists and optometrists who specialize in macular degeneration, including clinics that offer device-based therapy for appropriate patients with dry age-related macular degeneration (AMD). Because no independent ranking of dry AMD providers exists in Canada, the most reliable approach is to search through professional regulatory directories, ask a family physician for a referral and contact clinics directly to ask about their AMD focus and the range of management options they offer.1
The College of Physicians and Surgeons of British Columbia and the College of Health and Care Professionals of British Columbia (CHCPBC) both maintain registries of licensed practitioners. The Canadian Ophthalmological Society’s find-a-specialist tool allows patients to search by province. For patients specifically interested in device-based therapy, asking a potential provider whether they offer authorized treatment options for dry AMD and what their assessment process involves is the most direct path to finding appropriate care.23
The Dry AMD Care Landscape in Vancouver
As one of Canada’s largest cities, Vancouver offers a range of eye care services, from general optometry practices to academic medical centers with dedicated retinal programs. Patients with dry AMD are most likely to receive specialized care from ophthalmologists or optometrists who have a particular interest in macular disease, rather than from general practitioners who see eye conditions across the full spectrum.1
Access to a broader range of management options, including newer device-based therapies, is generally better in Vancouver than in smaller communities across British Columbia. Patients in Metro Vancouver and the surrounding region, including the Fraser Valley, the North Shore, and the Tri-Cities, are within practical reach of specialized AMD care. Patients in more remote parts of the province may need to travel or arrange an initial telehealth consultation before committing to in-person treatment.
Types of Providers Who Manage Dry AMD in Vancouver
Ophthalmologists are the most specialized clinical option for dry AMD management. They are medical doctors who have completed residency training in ophthalmology and may have pursued further subspecialty fellowship training in retinal disease. In academic and hospital settings in Vancouver, retinal specialists manage the full spectrum of AMD presentations, including patients requiring anti-VEGF injections for wet AMD and those seeking management options for dry AMD. Referral from a family physician or optometrist is typically required to access ophthalmology services under British Columbia’s healthcare system.2
Optometrists play a significant role in the dry AMD care community in Vancouver. They examine eyes, diagnose AMD, monitor progression through imaging and visual function testing, and may offer or co-manage device-based therapies with ophthalmology colleagues. For many patients, an optometrist is the first point of contact after a dry AMD diagnosis and remains a consistent presence in ongoing monitoring. Some optometry practices in Vancouver have developed a particular focus on macular degeneration and may offer a wider range of management options than a general optometry office.3
Specialized macular disease clinics, which focus specifically on conditions affecting the macula, tend to offer the broadest range of management options. These clinics are more likely to be aware of and offer newer approaches, including authorized device-based therapy, and their clinical teams are typically more experienced in communicating with patients about the nuances of dry AMD management, including realistic expectations for different treatment approaches.1
How to Find Dry AMD Providers in Vancouver
Several resources are available to Vancouver patients searching for a dry AMD provider. The College of Physicians and Surgeons of BC maintains a public registry of licensed physicians, including ophthalmologists, that can be searched by specialty and location. The College of Health and Care Professionals of BC (CHCPBC) similarly maintains a registry of licensed optometrists in the province.23
The Canadian Ophthalmological Society’s find-a-specialist tool allows patients to search for ophthalmologists by province and, in some cases, by subspecialty interest. The Canadian Association of Optometrists also offers a find-an-optometrist directory. These tools identify registered practitioners but do not rank or endorse specific providers.2
A family physician or general practitioner is often the most practical starting point for patients who do not already have an established eye care relationship. A GP can issue a referral to an ophthalmologist under BC’s Medical Services Plan, provide guidance on which specialists in the area have a focus on macular degeneration and help ensure continuity of care between providers.
Patients who already see an optometrist or general ophthalmologist for AMD and want to explore newer management options, including device-based therapy, can ask their current provider directly whether they offer these options or can refer to a colleague who does. A referral within an established clinical relationship is often the most efficient path.
What to Look for when Evaluating a Vancouver AMD Provider
Not all eye care practices in Vancouver offer the same depth of AMD management. When evaluating a potential provider, patients should consider a few key factors.
First, the provider should be a regulated professional with a verifiable registration in their respective college. This is a baseline requirement, not a differentiator, but it should always be confirmed. Both the College of Physicians and Surgeons of BC and the College of Health and Care Professionals of BC (CHCPBC) allow public verification of practitioner registration status.23
Second, the clinic should use retinal imaging, specifically optical coherence tomography (OCT), as a standard part of AMD assessment and monitoring. OCT imaging is essential for accurately staging dry AMD, tracking progression, and making informed decisions about treatment. A practice that does not use OCT for AMD monitoring is not equipped to manage the condition comprehensively.1
Third, a good AMD provider should be willing to discuss the full range of currently available management options, not only the ones they personally offer. This includes AREDS2 supplementation when appropriate, lifestyle modifications, low-vision referral when needed, and device-based therapy when clinically indicated. A provider who has not mentioned that device-based therapy is now authorized for dry AMD may not be up to date on the current treatment landscape.4
Fourth, realistic communication about outcomes is a marker of a trustworthy practice. A provider who presents any treatment as a certain fix or who downplays the importance of ongoing monitoring is not giving the patient an accurate picture. The best AMD providers are honest about what each option can and cannot do and help patients set expectations accordingly.
Device-Based Therapy in Vancouver
Device-based therapy for dry AMD is available in the Vancouver area. MacuMira, a Health Canada–authorized treatment device indicated to improve visual function in patients with dry AMD, is offered through clinics in Vancouver and across British Columbia. It is noninvasive, delivered in a supervised clinical setting and supported by a published clinical trial and real-world use across hundreds of clinics in multiple countries.4
Patients who are interested in device-based therapy should ask their eye care provider whether it is available at their current clinic or through a referral. If the provider is unfamiliar with MacuMira or similar authorized options, the patient may want to seek a second opinion from a practice with a specific focus on dry AMD management. Eligibility for device-based therapy depends on a clinical assessment, and not every patient with dry AMD will be an appropriate candidate.4
Coverage and Cost Considerations in British Columbia
In BC, ophthalmology visits for medically necessary assessments and treatment are generally covered under the Medical Services Plan when referred by a GP. Routine optometry visits for patients over 18 and under 65 without a qualifying medical condition are typically not covered, though AMD typically qualifies as a medical condition for coverage assessment purposes. Patients should confirm coverage with their provider and with BC’s Medical Services Plan before their first appointment.5
Device-based therapy for dry AMD is currently an out-of-pocket expense for most patients. Some extended health benefit plans and health spending accounts may cover part of the cost. Patients who are concerned about cost should ask the clinic about its fee structure and whether any payment options are available before committing to treatment.4
What to Ask a Potential Dry AMD Provider in Vancouver
- Are you registered with the College of Physicians and Surgeons of BC or the College of Health and Care Professionals of BC (CHCPBC)?
- Do you use OCT imaging for AMD staging and monitoring?
- What range of dry AMD management options do you offer, including device-based therapy?4
- If you do not offer device-based therapy, can you refer me to a clinic that does?
- What does your assessment process involve before recommending any specific treatment?
- What outcomes are realistic for someone at my stage of dry AMD?
- Is this treatment covered by BC’s Medical Services Plan or is it an out-of-pocket cost?5
Key Takeaway
Vancouver patients with dry AMD have access to a range of eye care providers, from general optometrists to retinal specialists, some of whom offer device-based therapy in addition to monitoring and supplementation. No independent provider ranking exists, so the most reliable approach is to use professional regulatory directories, seek a GP referral and contact clinics directly to ask about their AMD focus and the options they offer. A good AMD provider uses OCT imaging, honestly discusses the full range of available management options, and sets realistic expectations about treatment outcomes.
Disclaimer
This article is for educational purposes only and does not constitute a referral or endorsement of any specific provider, clinic or treatment. Patients should independently verify provider credentials and coverage information. Information about BC Medical Services Plan coverage is general in nature; patients should confirm their specific coverage with their provider and with the Ministry of Health.
Glossary
Dry AMD (dry age-related macular degeneration): A progressive retinal condition affecting the macula and central vision. Managed through monitoring, lifestyle changes, supplementation and device-based therapy for appropriate patients.
MacuMira: A Health Canada–authorized treatment device indicated to improve visual function in patients with dry AMD. Noninvasive, delivered under the supervision of an eye care professional. Not indicated for wet AMD.
Ophthalmologist: A medical doctor specializing in eye disease diagnosis and treatment. Licensed in BC by the College of Physicians and Surgeons of BC.
Optometrist: A regulated eye care professional who examines eyes, diagnoses conditions including AMD and manages ongoing eye health. Licensed in BC by the College of Health and Care Professionals of BC (CHCPBC).
College of Physicians and Surgeons of BC (CPSBC): The regulatory body for medical doctors in British Columbia, including ophthalmologists. Maintains a public registry of licensed physicians.
College of Health and Care Professionals of BC (CHCPBC): The regulatory body for optometrists in British Columbia. Maintains a public registry of licensed optometrists.
Optical coherence tomography (OCT): A noninvasive retinal imaging technology producing high-resolution cross-sectional images of the macula. Essential for staging and monitoring dry AMD.
BC Medical Services Plan (MSP): British Columbia’s publicly funded health insurance program. Covers medically necessary physician services including referred ophthalmology appointments.
AREDS2 formula: A nutritional supplement shown in the Age-Related Eye Disease Study 2 to reduce progression risk in eligible patients with intermediate or advanced dry AMD.
Geographic atrophy: An advanced stage of dry AMD in which retinal pigment epithelium cells and photoreceptors break down, causing permanent central vision loss.
References
1. Age-Related Macular Degeneration. National Eye Institute, National Institutes of Health. Last reviewed November 2023. Accessed June 2026. https://www.nei.nih.gov/eye-health-information/eye-conditions-and-diseases/age-related-macular-degeneration.
2. Physician Directory. College of Physicians and Surgeons of British Columbia. Date not listed. Accessed June 2026. https://www.cpsbc.ca/directory.
3. Optometrist Directory. College of Health and Care Professionals of British Columbia. Date not listed. Accessed June 2026. https://chcpbc.alinityapp.com/client/publicdirectory.
4. Evaluation of visual acuity in dry AMD patients after microcurrent electrical stimulation. Parkinson KM, Sayre EC, Tobe SW. International Journal of Retina and Vitreous. Published May 2023. Accessed June 2026. https://macumira.com/wp-content/uploads/2025/07/MacuMira-Clinical-Trial.pdf.
5. Medical Services Plan. Government of British Columbia, Ministry of Health. Date not listed. Accessed June 2026. https://www2.gov.bc.ca/gov/content/health/health-drug-coverage/msp.
